Chang RJ: A practical approach to the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol. 2004, 191 (3): 713-7. 10.1016/j.ajog.2004.04.045.
Article
PubMed
Google Scholar
Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev. 2003, 24: 302-312. 10.1210/er.2003-0004.
Article
PubMed
Google Scholar
Spritzer PM, Morsch DM, Wiltgen D: Polycystic ovary syndrome associated neoplasms. Arq Bras Endocrinol Metabol. 2005, 49 (5): 805-10.
Article
PubMed
Google Scholar
Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR: Polycystic ovary syndrome and gynecological cancers: is there a link?. Gynecol Endocrinol. 2005, 20 (4): 200-8. 10.1080/09513590400021201.
Article
PubMed
Google Scholar
Balen A: Polycystic ovary syndrome and cancer. Hum Reprod Update. 2001, 7 (6): 522-5. 10.1093/humupd/7.6.522.
Article
CAS
PubMed
Google Scholar
Donaldson CJ, Crapanzano JP, Watson JC, Levine EA, Batzer MA: PROGINS Alu insertion and human genomic diversity. Mutat Res. 2002, 25;501 (1–2): 137-41.
Article
Google Scholar
Rousseau Merck MF, Misrahi M, Loosfelt H, Milgrom E, Berger R: Localization of the human progesterone receptor gene to chromosome 11q22-q23. Hum Genet. 1987, 77: 280-282. 10.1007/BF00284486.
Article
CAS
PubMed
Google Scholar
Punyadeera C, Verbost P, Groothuis P: Oestrogen and progestin responses in human endometrium. J Steroid Biochem Mol Biol. 2003, 84 (4): 393-410. 10.1016/S0960-0760(03)00061-X.
Article
CAS
PubMed
Google Scholar
Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993, 15: 17-35.
CAS
PubMed
Google Scholar
Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med. 1999, 130: 262-9.
Article
CAS
PubMed
Google Scholar
McKenna NJ, Kieback DG, Carney DN, Fanning M, McLinden J, Headon DR: A germline TaqI restriction fragment length polymorphismin the progesterone receptor gene in ovarian carcinoma. Br J Cancer. 1995, 71: 451-5.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA: Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer. 1998, 78: 277.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM: No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina. Cancer Epidemiol Biomarkers Prev. 2003, 12: 226-7.
CAS
PubMed
Google Scholar
Fabjani G, Tong D, Czerwenka K, Schuster E, Speiser P, Zeillinger R: Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Res Treat. 2002, 72: 131-7. 10.1023/A:1014813931765.
Article
CAS
PubMed
Google Scholar
Brooks-Asplund EM, Tupper CE, Daun JM, Kenney WL, Cannon JG: Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women. Cytokine. 2002, 19: 193-200. 10.1006/cyto.2002.1963.
Article
CAS
PubMed
Google Scholar
Manning PJ, Sutherland WH, Allum AR, de Jong SA, Jones SD: Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with type 2 diabetes. Diabet Med. 2002, 19: 847-852. 10.1046/j.1464-5491.2002.00808.x.
Article
CAS
PubMed
Google Scholar
The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19 (1): 41-7. 10.1093/humrep/deh098.
Article
Google Scholar
Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961, 21: 1440-1447.
Article
CAS
PubMed
Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.
Article
CAS
PubMed
Google Scholar
Yagi K: Lipid peroxides in hepatic, gastrointestinal and pancreatic diseases. Free radicals in Diagnostic Medicine. Edited by: Armstrong D. 1994, New York, NY, Plenum Press, 165-169.
Chapter
Google Scholar
Miranda KM, Espey MG, Wink DA: A rapid, simple spectrophometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001, 5: 62-71. 10.1006/niox.2000.0319.
Article
CAS
PubMed
Google Scholar
Sedlak J, Lindsay RH: Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968, 25: 192-205. 10.1016/0003-2697(68)90092-4.
Article
CAS
PubMed
Google Scholar
Risch HA, Bale AE, Beck PA, Zheng W: PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer EpidemiolBiomarkers Prev. 2006, 15 (9): 1738-41. 10.1158/1055-9965.EPI-06-0272.
CAS
Google Scholar
Lau KM, Mok SC, Ho SM: Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA. 1999, 96: 5722-7. 10.1073/pnas.96.10.5722.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rowe SM, Coughlan SJ, McKenna NJ, Garrett E, Kieback DG, Carney DN, Headon DR: Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res. 1995, 1;55 (13): 2743-5.
Google Scholar
Agoulnik IU, Tong XW, Fischer DC, Korner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG: A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab. 2004, 89 (12): 6340-7. 10.1210/jc.2004-0114.
Article
CAS
PubMed
Google Scholar
Ohshima H, Tatemichi M, Sawa T: Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys. 417 (1): 3-11. 10.1016/S0003-9861(03)00283-2. 2003 Sep 1
Hofseth LJ, Wargovich MJ: Inflammation, cancer, and targets of ginseng. J Nutr. 2007, 137 (1): 183S-5S.
CAS
PubMed
Google Scholar
Bickerton AS, Clark N, Meeking D, Shaw KM, Crook M, Lumb P, Turner C, Cummings MH: Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol. 2005, 58 (2): 151-4. 10.1136/jcp.2003.015271.
Article
PubMed Central
CAS
PubMed
Google Scholar
Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Annu Rev Med. 1998, 49: 31-62. 10.1146/annurev.med.49.1.31.
Article
CAS
PubMed
Google Scholar
Jacobsen DW: Homocysteine and vitamins in cardiovascular disease. Clin Chem. 1998, 44: 1833-1843.
CAS
PubMed
Google Scholar
Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V: Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance – the Chennai Urban Rural Epidemiology Study (CURES). Metabolism. 2006, 55 (9): 1232-8. 10.1016/j.metabol.2006.05.008.
Article
CAS
PubMed
Google Scholar
Diamanti-Kandarakis E: Insulin resistance in PCOS. Endocrine. 2006, 30 (1): 13-7. 10.1385/ENDO:30:1:13.
Article
CAS
PubMed
Google Scholar
Rifici VA, Schneider SH, Khachadurian AK: Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis. 1994, 107: 99-108. 10.1016/0021-9150(94)90145-7.
Article
CAS
PubMed
Google Scholar
Quiñones Galvan A, Muscelli E, Catalano C, Natali A, Sanna G, Masoni A, Bernardini B, Barsacchi R, Ferrannini E: Insulin decreases circulating vitamin E levels in humans. Metabolism. 1996, 45: 998-1003. 10.1016/S0026-0495(96)90270-X.
Article
Google Scholar
Joo MH, Maehata E, Adachi T, Ishida A, Murai F, Mesaki N: The relationship between exercise-induced oxidative stress and the menstrual cycle. Eur J Appl Physiol. 2004, 93 (1–2): 82-6. 10.1007/s00421-004-1168-4.
Article
CAS
PubMed
Google Scholar
O MH, Maehata E, Adachi T, Ishida A, Murai F, Mesaki N: The relationship between exercise-induced oxidative stress and the menstrual cycle. Eur J Appl Physiol. 2004, 93 (1–2): 82-6.
Google Scholar
Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K: Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem. 2003, 36 (7): 557-62. 10.1016/S0009-9120(03)00094-8.
Article
CAS
PubMed
Google Scholar
Nicotera TM, Privalle C, Wang TC, Oshimura M, Barrett JC: Differential proliferative responses of Syrian hamster embryo fibroblasts to paraquat-generated superoxide radicals depending on tumor suppressor gene function. Cancer Res. 1994, 15;54 (14): 3884-8.
Google Scholar
Murrell GA, Francis MJ, Bromley L: Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990, 1;265 (3): 659-65.
Article
Google Scholar
Randerath K, Randerath E, Smith CV, Chang J: Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem Res Toxicol. 1996, 9 (1): 247-54. 10.1021/tx950085v.
Article
CAS
PubMed
Google Scholar
Toyokuni S, Okamoto K, Yodoi J, Hiai H: Persistent oxidative stress in cancer. FEBS Lett. 1995, 16;358 (1): 1-3. 10.1016/0014-5793(94)01368-B.
Article
Google Scholar
Pelicano H, Carney D, Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004, 7 (2): 97-110. 10.1016/j.drup.2004.01.004.
Article
CAS
PubMed
Google Scholar
Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME: Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994, 91: 6369-6373. 10.1073/pnas.91.14.6369.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wild RA, Applebaum-Bowden D, Demers LM, Bartholomew M, Landis JR, Hazzard WR, Santen RJ: Lipoprotein lipids in women with androgen excess: independent associations with increased insulin andandrogen. Clin Chem. 1990, 36 (2): 283-9.
CAS
PubMed
Google Scholar
Alexandraki K, Protogerou AD, Papaioannou TG, Piperi C, Mastorakos Gw, Lekakis J, Panidis D, Diamanti-Kandarakis E: Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Hormones (Athens). 2006, 5 (2): 126-36.
Article
Google Scholar